[go: up one dir, main page]

WO2010122574A3 - Coated capsule - Google Patents

Coated capsule Download PDF

Info

Publication number
WO2010122574A3
WO2010122574A3 PCT/IN2010/000242 IN2010000242W WO2010122574A3 WO 2010122574 A3 WO2010122574 A3 WO 2010122574A3 IN 2010000242 W IN2010000242 W IN 2010000242W WO 2010122574 A3 WO2010122574 A3 WO 2010122574A3
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
coating composition
therapeutically active
coated capsules
coated capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2010/000242
Other languages
French (fr)
Other versions
WO2010122574A2 (en
Inventor
Yashoraj Rupsinh Zala
Nitin Bhalachandra Dharmadhikari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharma Advanced Research Co Ltd
Original Assignee
Sun Pharma Advanced Research Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Research Co Ltd filed Critical Sun Pharma Advanced Research Co Ltd
Publication of WO2010122574A2 publication Critical patent/WO2010122574A2/en
Publication of WO2010122574A3 publication Critical patent/WO2010122574A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to coated capsules comprising therapeutically active ingredient and pharmaceutically acceptable carrier and the coating composition (4) comprising a hydrophobic polymer and a hydrophilic substance, wherein the said coating composition is applied directly to the capsule and wherein the coated capsules upon contact with the aqueous environment (1) break open into the cap (2) and the body (3) and thereby providing a programmed release of the therapeutically active ingredient.
PCT/IN2010/000242 2009-04-20 2010-04-15 Coated capsule Ceased WO2010122574A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1030/MUM/2009 2009-04-20
IN1030MU2009 2009-04-20

Publications (2)

Publication Number Publication Date
WO2010122574A2 WO2010122574A2 (en) 2010-10-28
WO2010122574A3 true WO2010122574A3 (en) 2010-12-16

Family

ID=43011550

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000242 Ceased WO2010122574A2 (en) 2009-04-20 2010-04-15 Coated capsule

Country Status (1)

Country Link
WO (1) WO2010122574A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108686252B (en) * 2018-06-11 2021-05-18 深圳英凡妮生物科技有限公司 Nano-silver antibacterial dressing with chitosan-poloxamer as matrix and preparation method and application thereof
EP4327806A4 (en) * 2021-04-20 2024-10-23 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Capsule for specific drug delivery and preparation method therefor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4329503A1 (en) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmaceutical preparations for the targeted treatment of Crohn's disease and ulcerative colitis
US6503883B1 (en) * 1993-09-01 2003-01-07 Novartis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
WO2008132727A2 (en) * 2007-04-26 2008-11-06 Technion Research And Development Foundation Ltd Oral delivery of proteins and peptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4329503A1 (en) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmaceutical preparations for the targeted treatment of Crohn's disease and ulcerative colitis
US6503883B1 (en) * 1993-09-01 2003-01-07 Novartis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
WO2008132727A2 (en) * 2007-04-26 2008-11-06 Technion Research And Development Foundation Ltd Oral delivery of proteins and peptides

Also Published As

Publication number Publication date
WO2010122574A2 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
WO2011049309A3 (en) Pharmaceutical composition with both immediate and extended release characteristics
WO2010111232A3 (en) Drug delivery medical device
EP4477210A3 (en) Process for preparing a coated hard shell capsule
AU2003286994A1 (en) Modified release pharmaceutical composition
SI1906939T1 (en) Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values
WO2010146591A3 (en) Methods and devices for delivery of pharmaceutical agents within orifices of the body
WO2006020660A3 (en) Coated medical device having an increased coating surface area
WO2008135090A8 (en) Solid dosage forms comprising an enteric coating with accelerated drug release
NZ594839A (en) Microencapsulated insecticide formulations
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
WO2010024615A3 (en) Method for manufacturing sustained release microsphere by solvent flow evaporation method
WO2006103661A3 (en) Controlled absorption of statins in the intestine
WO2006083799A3 (en) Suspending vehicles comprising a hydrophilic solvent, a hydrophobic solvent, a polymer and the suitable pump-driven dosage form
WO2017171535A3 (en) Compositions
WO2005092297A3 (en) A stable pharmaceutical composition comprising an acid labile drug
WO2008139947A1 (en) Prophylactic or therapeutic agent for diarrhea
WO2007114890A8 (en) Fluid treatment of a polymeric coating on an implantable medical device
WO2009013019A3 (en) Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions
WO2008123395A1 (en) Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
WO2009072334A1 (en) Core particle for pharmaceutical preparation
WO2010122574A3 (en) Coated capsule
WO2006103672A3 (en) Spherically shaped substances
WO2010026557A3 (en) Coated medical device and method of coating a medical device to reduce, fibrosis and capsule formation
WO2008002469A3 (en) Thin stent coating

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10766752

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10766752

Country of ref document: EP

Kind code of ref document: A2